These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinico-radiological aspects of neurocysticercosis in pediatric population in a tertiary hospital. Shrestha B; Mainali P; Sayami S; Shrestha OK JNMA J Nepal Med Assoc; 2013; 52(191):483-8. PubMed ID: 24907956 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the performance of 5 commercialized enzyme immunoassays for the detection of Taenia solium antibodies and for the diagnosis of neurocysticercosis. Carod JF; Randrianarison M; Razafimahefa J; Ramahefarisoa RM; Rakotondrazaka M; Debruyne M; Dautigny M; Cazal P; Andriantseheno ML; Charles ER Diagn Microbiol Infect Dis; 2012 Jan; 72(1):85-9. PubMed ID: 22085773 [TBL] [Abstract][Full Text] [Related]
25. A clinico-serological study of neurocysticercosis in patients with ring enhancing lesions in CT scan of brain. Kotokey RK; Lynrah KG; De A J Assoc Physicians India; 2006 May; 54():366-70. PubMed ID: 16909732 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for immunodiagnosis of neurocysticercosis using ELISA on cerebrospinal fluid samples. Suzuki LA; Arruda GC; Quagliato EM; Rossi QL Rev Soc Bras Med Trop; 2007; 40(2):152-5. PubMed ID: 17568880 [TBL] [Abstract][Full Text] [Related]
27. Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa. Foyaca-Sibat H; Cowan LD; Carabin H; Targonska I; Anwary MA; Serrano-Ocaña G; Krecek RC; Willingham AL PLoS Negl Trop Dis; 2009 Dec; 3(12):e562. PubMed ID: 19997629 [TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of Taenia solium antibodies in Vellore district, south India. Prabhakaran V; Raghava MV; Rajshekhar V; Muliyil J; Oommen A Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):246-50. PubMed ID: 18061224 [TBL] [Abstract][Full Text] [Related]
29. A population-based, case-control study of Taenia solium taeniasis and cysticercosis. Sánchez AL; Lindbäck J; Schantz PM; Sone M; Sakai H; Medina MT; Ljungström I Ann Trop Med Parasitol; 1999 Apr; 93(3):247-58. PubMed ID: 10562826 [TBL] [Abstract][Full Text] [Related]
30. Feasibility of baculovirus-expressed recombinant 10-kDa antigen in the serodiagnosis of Taenia solium neurocysticercosis. Lee EG; Lee MY; Chung JY; Je EY; Bae YA; Na BK; Kim TS; Eom KS; Cho SY; Kong Y Trans R Soc Trop Med Hyg; 2005 Dec; 99(12):919-26. PubMed ID: 16143356 [TBL] [Abstract][Full Text] [Related]
31. Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico. Hernández M; Astudillo OG; Diego G; de-la-Rosa-Arana JL; Meza-Lucas A; García-Rodea R; Romo ML; Toledo A; Parkhouse RM; Garate T; Sciutto E; Fleury A Parasitol Res; 2019 Oct; 118(10):2891-2899. PubMed ID: 31418112 [TBL] [Abstract][Full Text] [Related]
32. Neurocysticercosis in a north Indian hospital. Mohanty S; Deb M; Aggarwal P Trop Doct; 2008 Jul; 38(3):177-9. PubMed ID: 18628553 [TBL] [Abstract][Full Text] [Related]
33. Relative seroprevalence of cysticercus antigens and antibodies and antibodies to Taenia ova in a population sample in south India suggests immunity against neurocysticercosis. Jayaraman T; Prabhakaran V; Babu P; Raghava MV; Rajshekhar V; Dorny P; Muliyil J; Oommen A Trans R Soc Trop Med Hyg; 2011 Mar; 105(3):153-9. PubMed ID: 21216417 [TBL] [Abstract][Full Text] [Related]
34. Correlation between the clinico radiological heterogeneity and the immune-inflammatory profiles in pediatric patients with neurocysticercosis from a tertiary referral centre. Kashyap B; Das S; Jain S; Agarwal A; Kaushik JS; Kaur IR J Trop Pediatr; 2012 Aug; 58(4):320-3. PubMed ID: 22123942 [TBL] [Abstract][Full Text] [Related]
35. A study of neurocysticercosis in the foothills of the Himalayas. Kumar A; Khan SA; Khan S; Das S; Anurag ; Negi KS Int J Infect Dis; 2006 Jan; 10(1):79-82. PubMed ID: 16289788 [TBL] [Abstract][Full Text] [Related]
36. Profile of children admitted with seizures in a tertiary care hospital of Western Nepal. Adhikari S; Sathian B; Koirala DP; Rao KS BMC Pediatr; 2013 Mar; 13():43. PubMed ID: 23536998 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the enzyme-linked immunoelectrotransfer blot assay for diagnosis of neurocysticercosis in children. Aguilar-Rebolledo F; Meza-Lucas A; Torres J; Cedillo-Rivera R; Enciso A; Garcia RC; Muñoz O; Correa D J Child Neurol; 2002 Jun; 17(6):416-20. PubMed ID: 12174961 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of IgG4 and total IgG antibodies against cysticerci and peptide antigens for the diagnosis of human neurocysticercosis by ELISA. Intapan PM; Khotsri P; Kanpittaya J; Chotmongkol V; Maleewong W; Morakote N Asian Pac J Allergy Immunol; 2008 Dec; 26(4):237-44. PubMed ID: 19317343 [TBL] [Abstract][Full Text] [Related]
39. Dot-ELISA for the diagnosis of neurocysticercosis. Biswas R; Parija SC; Narayan SK Rev Inst Med Trop Sao Paulo; 2004; 46(5):249-52. PubMed ID: 15517026 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of an enzyme immunoassay for clinical diagnosis of neurocysticercosis in symptomatic patients. Carvalho Junior RM; Costa DL; Soares SC; Costa CH Rev Soc Bras Med Trop; 2010; 43(6):647-50. PubMed ID: 21181016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]